CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-17 | Mercier Johanna Director | Grant or award · Non-Qualified Stock Option | +4,290 | 4,290 | ||
| 2023-05-17 | Mercier Johanna Director | Grant or award · Restricted Stock Unit | +2,100 | 2,100 | ||
| 2023-05-17 | LYONS GARY A Director | Grant or award · Non-Qualified Stock Option | +4,290 | 4,290 | ||
| 2023-05-17 | LYONS GARY A Director | Grant or award · Restricted Stock Unit | +2,100 | 2,100 | ||
| 2023-05-01 | RASTETTER WILLIAM H Director | Option exercise 10b5-1 | +7,625 | $12.71 | $97K | 47,085 |
| 2023-05-01 | RASTETTER WILLIAM H Director | Sale 10b5-1 | −4,300 | $101.43 | $436K | 42,785 |
| 2023-05-01 | RASTETTER WILLIAM H Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −7,625 | $12.71 | $97K | 0 |
| 2023-05-01 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −11,397 | $103.89 | $1.2M | 16,169 |
| 2023-04-25 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −100 | $103.82 | $10K | 27,561 |
| 2023-04-24 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −14,400 | $103.48 | $1.5M | 26,644 |
| 2023-04-21 | RASTETTER WILLIAM H Director | Option exercise 10b5-1 | +10,765 | $12.71 | $137K | 45,494 |
| 2023-04-21 | RASTETTER WILLIAM H Director | Sale 10b5-1 | −6,034 | $105.04 | $634K | 39,460 |
| 2023-04-21 | RASTETTER WILLIAM H Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −10,765 | $12.71 | $137K | 7,625 |
| 2023-04-19 | RASTETTER WILLIAM H Director | Option exercise 10b5-1 | +1,610 | $12.71 | $20K | 35,632 |
| 2023-04-19 | RASTETTER WILLIAM H Director | Sale 10b5-1 | −903 | $105.00 | $95K | 34,729 |
| 2023-04-19 | RASTETTER WILLIAM H Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −1,610 | $12.71 | $20K | 18,390 |
| 2023-02-13 | Delaet Ingrid Chief Regulatory Officer | Grant or award · Stock Option | +33,771 | 33,771 | ||
| 2023-02-13 | Delaet Ingrid Chief Regulatory Officer | Grant or award · Restricted Stock Unit | +5,434 | 5,434 | ||
| 2023-02-13 | ROBERTS EIRY Chief Medical Officer | Grant or award · Stock Option | +52,532 | 52,532 | ||
| 2023-02-13 | ROBERTS EIRY Chief Medical Officer | Grant or award · Restricted Stock Unit | +8,453 | 8,453 |
Page 45 of 49 · 963 trades